Profil
Nicholas Robbins-Cherry is currently the Chief Financial Officer, Director & Vice President at Ixaka Ltd. He previously worked as the Finance Director at CACI Ltd. from 2008 to 2013 and at The Marketing Practice (UK) Ltd. from 2013 to 2014.
In 2019, he briefly served as the Secretary at Biodexa Pharmaceuticals Plc.
Postes actifs de Nicholas Robbins-Cherry
| Sociétés | Poste | Début |
|---|---|---|
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Directeur Financier/CFO | 01/10/2021 |
Anciens postes connus de Nicholas Robbins-Cherry
| Sociétés | Poste | Fin |
|---|---|---|
| BIODEXA PHARMACEUTICALS PLC | Directeur Financier/CFO | 09/09/2019 |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Directeur Financier/CFO | 01/01/2014 |
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Directeur Financier/CFO | 01/01/2013 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CACI Ltd.
CACI Ltd. Data Processing ServicesTechnology Services Provides data and technology solutions | Technology Services |
Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Designs and manufactures nanomedicines | Health Technology |
The Marketing Practice (UK) Ltd.
The Marketing Practice (UK) Ltd. Advertising/Marketing ServicesCommercial Services Operates as a B2B marketing agency | Commercial Services |
Ixaka Ltd.
Ixaka Ltd. BiotechnologyHealth Technology Operates as a preclinical-stage immunotherapy biotech company | Health Technology |
















